CASP12 Antibody

What is the function of CASP12 and why is it relevant to study?

CASP12 (Caspase-12) belongs to the inflammatory caspase family and functions through interactions with other caspases. In its active form, CASP12 activates effector caspases like Caspase-3 and Caspase-7, which ultimately lead to apoptotic cell death . The human variant of CASP12 has attracted significant research interest due to its unique characteristics that differ from other inflammatory caspases. While functional CASP12 appears to be confined to people of African descent and is linked with susceptibility to sepsis, it shows contradictory roles in inflammation regulation .

Human CASP12 has been detected in multiple tissues including heart, kidney, liver, lung, pancreas, small intestine, spleen, stomach, thymus, and testis, suggesting widespread physiological relevance . Recent studies have revealed its involvement in NF-κB signaling pathway regulation, highlighting its potential role in inflammation and cancer progression .

For optimal preservation of antibody activity:

• Store at -20°C for long-term storage. Antibodies are typically stable for one year after shipment when stored properly .

• For short-term storage (up to 2 weeks), refrigeration at 2-8°C is sufficient .

• The storage buffer typically consists of PBS with 0.02% sodium azide and 50% glycerol at pH 7.3, which helps maintain antibody stability .

• To prevent freeze-thaw cycles that can degrade antibody quality, aliquot the antibody into smaller volumes before freezing, especially for larger sized antibody preparations .

• Some preparations may contain 0.1% BSA for additional stability, particularly in smaller volume formats (20μl) .

The shelf life of properly stored antibodies is typically one year, but activity should be validated before use in critical experiments if the antibody has been stored for extended periods.

What are the key considerations when selecting a CASP12 antibody for specific research applications?

When selecting a CASP12 antibody, consider these critical factors:

• Target region specificity: Different antibodies target distinct regions of CASP12, which can affect detection sensitivity and specificity:

  • N-terminal region (aa 1-50) antibodies

  • Middle region (aa 100-150) antibodies

  • Central region (aa 165-193) antibodies

• Species reactivity: Verify compatibility with your experimental model. Some antibodies react with:

  • Human samples only

  • Mouse samples only

  • Both human and mouse samples

  • Other species through predicted cross-reactivity

• Isoform detection: Human CASP12 exists as a full-length protein and a pseudogene variant. Ensure the antibody detects your isoform of interest, as molecular weights vary:

  • Calculated MW: 39 kDa

  • Observed MW: 36-42 kDa, 50 kDa

• Validation data: Review published literature citing the antibody to confirm reliable performance in your specific application. For example, anti-CASP12 antibody 55238-1-AP has been cited in 99 publications for Western blot applications .

• Control experiments: Plan appropriate positive and negative controls, including knockout/knockdown validation where possible.

How should immunoprecipitation experiments be designed to study CASP12 interactions with other proteins?

For successful CASP12 immunoprecipitation experiments:

• Antibody selection: Use antibodies specifically validated for IP applications. For example, anti-CASP12 antibody 55238-1-AP has been validated for IP in HEK-293 cells .

• Protein complex preservation:

  • Use gentle lysis buffers containing protease inhibitors

  • Maintain samples at 4°C throughout processing

  • Consider using crosslinking agents for transient interactions

• Experimental protocol:

  • Use 0.5-4.0 μg antibody per 1.0-3.0 mg of total protein lysate

  • Include appropriate controls (IgG control, input sample)

  • For co-immunoprecipitation, verify reciprocal pull-down where possible

• Detection strategy: Research has successfully detected CASP12-IKK complex formation using this approach:

  • Immunoprecipitate CASP12 from transfected cells and detect IKKα/β by Western blot

  • Confirm interaction through reciprocal co-IP with anti-IKKα antibody

  • Examine interaction with additional complex components like NEMO

This methodology has revealed that CASP12 physically interacts with IKK complex components, with increased IKKα and IKKβ levels detected in immunoprecipitates from CASP12-transfected cells .

What controls are essential when using CASP12 antibodies for immunohistochemistry?

For reliable IHC results with CASP12 antibodies:

• Positive tissue controls: Include tissues known to express CASP12, such as:

  • Human: heart, prostate, kidney, liver tissues

  • Mouse: liver tissue

• Negative controls:

  • Primary antibody omission

  • Isotype control antibody

  • Blocking peptide competition (when available)

  • CASP12 knockout/knockdown tissue (ideal but not always available)

• Antigen retrieval optimization:

  • Test multiple retrieval methods (suggested options include TE buffer pH 9.0 or citrate buffer pH 6.0)

  • Optimize incubation times and temperatures

• Antibody dilution: Test a range of dilutions (e.g., 1:50-1:500) to determine optimal signal-to-noise ratio

• Signal validation: Consider dual-labeling with another CASP12 antibody targeting a different epitope to confirm specificity

Published studies demonstrate successful CASP12 detection in human heart tissue using 10μg/ml concentration of anti-pro-CASP12 antibody (ab8118) and in mouse liver tissue using ab8117 .

How does CASP12 regulate NF-κB signaling and what experimental approaches can verify this mechanism?

Research has established that CASP12 regulates NF-κB signaling through IκBα degradation, affecting inflammatory responses and cancer cell invasion. To investigate this mechanism:

• NF-κB reporter assays:

  • Co-transfect cells with pcDNA-CASP12 (pC12) and NF-κB reporter plasmid

  • Measure luciferase activity after 24 hours

  • Results show significantly increased NF-κB activity with CASP12 overexpression

• IκBα degradation analysis:

  • Transfect cells with increasing concentrations of pC12 (0.5-1 μg/ml)

  • Assess IκBα protein levels by Western blot

  • Data demonstrates dose-dependent decrease in IκBα expression with CASP12 overexpression

• Inhibitor studies:

  • Use BMS (specific IKK inhibitor) with CASP12-transfected cells

  • Measure NF-κB activity and IκBα expression

  • Results show decreased NF-κB activity and restored IκBα levels

• Peptide inhibitor experiments:

  • Apply Z-ATAD-fmk (CASP12 inhibitor) to CASP12-transfected cells

  • Assess NF-κB activity

  • Data shows concentration-dependent suppression of CASP12-induced NF-κB activity

• Physical interaction studies:

  • Perform co-immunoprecipitation with anti-CASP12 or anti-IKK antibodies

  • Western blot for associated proteins

  • Results demonstrate physical interaction between CASP12 and IKKα/β components

These methodological approaches collectively provide strong evidence for CASP12's role in NF-κB pathway activation through IKKα/β interaction and IκBα degradation.

What are the challenges in detecting CASP12 isoforms and how can they be addressed?

CASP12 detection presents several challenges due to its complex biology:

• Isoform complexity:

  • Human CASP12 exists as a full-length protein and a pseudogene variant

  • Observed molecular weights range from 36-42 kDa and 50 kDa despite calculated MW of 39 kDa

• Species-specific variations:

  • Functional form appears confined to people of African descent

  • Significant differences exist between human and mouse CASP12

• Antibody-specific detection:

  • Antibodies targeting different CASP12 regions may detect different forms

  • Epitope accessibility may vary in different experimental contexts

• Expression level variations:

  • Endogenous expression can be low in certain cell types

  • Expression may be induced during specific cellular stresses

To address these challenges:

• Multiple antibody approach:

  • Use antibodies targeting different epitopes:

    • N-terminal (aa 1-50)

    • Middle region (aa 100-150)

    • Central region (aa 165-193)

• Enhanced detection methods:

  • Consider signal amplification techniques

  • Optimize extraction methods for membrane-associated proteins

  • Use transfection models for overexpression studies

• Specific controls:

  • Include recombinant CASP12 protein as positive control

  • Use siRNA knockdown to validate specificity

  • Consider species-appropriate controls

• Technical optimization:

  • Adjust sample preparation (reducing vs. non-reducing conditions)

  • Optimize membrane transfer conditions for Western blot

  • Test different blocking agents to reduce background

How can researchers investigate the contradictory roles of CASP12 in inflammatory responses?

CASP12 demonstrates paradoxical roles in inflammation, acting as both a negative regulator and activator under different conditions . To investigate these contradictory functions:

• Cell-type specific analyses:

  • Compare CASP12 function across different immune cell types

  • Contrast effects in cancer cells versus normal cells

  • Analyze tissue-specific responses

• Stimulation-dependent studies:

  • Examine CASP12 responses to different inflammatory stimuli:

    • Lipopolysaccharide (LPS)

    • Phorbol-12-myristate-13-acetate (PMA)

    • TNF-α

  • Measure cytokine production using ELISA or multiplex assays

  • Evaluate NF-κB activity under varying conditions

• Genetic approaches:

  • Compare full-length CASP12 with pseudogene variant effects

  • Generate mutants with modified active sites (e.g., QACRG pentapeptide motif)

  • Use CRISPR/Cas9 to create knockout models

• Protein interaction investigations:

  • Map interaction networks in different contexts using:

    • Co-immunoprecipitation followed by mass spectrometry

    • Proximity labeling approaches

    • Yeast two-hybrid screening

• Signaling pathway analysis:

  • Evaluate direct effects on:

    • IκBα degradation

    • IKK complex activation

    • Effector caspase activation

  • Assess cross-talk with other inflammatory pathways

These methodological approaches can help reconcile the seemingly contradictory roles of CASP12 in inflammatory regulation, which may depend on cellular context, genetic background, and nature of inflammatory stimuli.

What are common pitfalls in CASP12 protein detection by Western blot and how can they be overcome?

Western blot detection of CASP12 presents several challenges:

• Multiple band detection:

  • CASP12 can appear at different molecular weights (36-42 kDa, 50 kDa)

  • Solution: Use positive controls with known molecular weights and include loading controls

• Low signal intensity:

  • Endogenous CASP12 expression may be low in some cell types

  • Solution: Optimize protein extraction methods, consider immunoprecipitation before Western blot, or use signal enhancers

• Non-specific binding:

  • Some antibodies may cross-react with other caspase family members

  • Solution: Validate specificity using blocking peptides, as demonstrated with ab8117 where antibody signal disappeared in presence of blocking peptide

• Sample preparation issues:

  • CASP12 may be sensitive to degradation during extraction

  • Solution: Use fresh samples, add protease inhibitors, maintain cold temperatures during processing

• Transfer efficiency problems:

  • Large proteins may transfer poorly to membranes

  • Solution: Optimize transfer conditions (time, buffer composition, membrane type)

Recommended protocol refinements:

How should researchers interpret contradictory data when studying CASP12 function?

When confronted with seemingly contradictory results in CASP12 research:

• Consider genetic variations:

  • Functional CASP12 is primarily found in people of African descent

  • The presence of pseudogene variants can affect detection and function

  • Verify the specific isoform present in your experimental system

• Evaluate context-dependency:

  • CASP12 shows different functions in different contexts:

    • Anti-inflammation characteristics shown in some studies

    • Pro-inflammatory role observed in others

  • Document all experimental conditions precisely

• Assess cell/tissue specificity:

  • CASP12's role may vary across different tissues

  • Expression is detected in multiple organs including heart, kidney, liver, lung, pancreas, small intestine, spleen, stomach, thymus and testis

  • Compare results across different cell types

• Examine interaction with other pathways:

  • CASP12 interacts with multiple signaling pathways:

    • NF-κB pathway through IKK interaction

    • Apoptotic pathway through effector caspase activation

    • Inflammatory responses through cytokine regulation

  • Evaluate which pathway dominates in your specific experimental system

• Technical validation:

  • Use multiple antibodies targeting different epitopes

  • Confirm findings with complementary techniques (e.g., IF, IP, functional assays)

  • Include genetic approaches (siRNA, CRISPR) to validate antibody specificity

Remember that biological contradictions often reflect complex reality rather than experimental error, particularly for proteins like CASP12 with context-dependent functions.

What methodological approaches are best for investigating CASP12's role in cell invasion and cancer progression?

To examine CASP12's involvement in cell invasion and cancer progression:

• Cell invasion assays:

  • Transfect cells with CASP12 expression vector or siRNA

  • Treat with PMA to induce invasion

  • Use transwell chambers coated with Matrigel

  • Quantify invading cells after 16-24 hours

  • Published data shows that CASP12 siRNA significantly decreases PMA-induced cell invasion in NPC cells

• Molecular mechanism analysis:

  • Assess MMP-9 and TIMP-1 expression by Western blot

  • Perform gelatin zymography to measure MMP activity

  • Evaluate NF-κB activation using reporter assays

  • Research demonstrates CASP12 siRNA knockdown efficiently decreases PMA-induced MMP-9 and TIMP-1 expressions

• Pharmacological intervention:

  • Use Z-ATAD-fmk (CASP12 inhibitor) to validate genetic approaches

  • Treat cells with varying concentrations to establish dose-dependency

  • Data shows Z-ATAD-fmk treatment abrogates PMA-mediated cell invasion by approximately 25% in NPC cell lines

• In vivo metastasis models:

  • Develop CASP12 overexpression or knockdown stable cell lines

  • Inject cells into appropriate animal models

  • Monitor tumor growth and metastatic spread

  • Analyze tissue samples for CASP12, MMP-9, and NF-κB pathway components

• Clinical correlation studies:

  • Examine CASP12 expression in patient-derived cancer tissues

  • Correlate expression with clinical parameters and survival data

  • Analyze association with markers of invasion and metastasis

This multi-faceted approach has established CASP12's role in enhancing cancer cell invasion through NF-κB activation and subsequent MMP-9 upregulation, providing potential targets for therapeutic intervention.

What emerging technologies might enhance CASP12 research?

Several cutting-edge technologies hold promise for advancing CASP12 research:

• Single-cell analysis:

  • Apply single-cell RNA sequencing to identify cell populations expressing CASP12

  • Use single-cell proteomics to assess protein-level variability

  • Examine cell-to-cell variation in CASP12 function within heterogeneous populations

• CRISPR-based approaches:

  • Generate precise CASP12 knockouts in various cell types

  • Create domain-specific mutations to dissect protein function

  • Develop CRISPR activation/inhibition systems for temporal control of CASP12 expression

• Advanced imaging techniques:

  • Apply super-resolution microscopy to visualize CASP12 localization

  • Use live-cell imaging with fluorescent CASP12 fusions to track dynamics

  • Implement proximity labeling (BioID, APEX) to map CASP12 interaction networks

• Structural biology integration:

  • Utilize cryo-EM to resolve CASP12 protein complexes

  • Apply hydrogen-deuterium exchange mass spectrometry to study conformational changes

  • Develop computational models of CASP12-protein interactions

• Multi-omics integration:

  • Combine transcriptomics, proteomics, and metabolomics data

  • Develop network models of CASP12's role in cellular signaling

  • Identify biomarkers associated with CASP12 activity

These technologies will provide deeper insights into CASP12's complex biology and potentially resolve contradictions in current understanding of its functions.

What are the most pressing unresolved questions in CASP12 biology?

Despite significant advances, several critical questions about CASP12 remain unanswered:

• Evolutionary and population significance:

  • Why is functional CASP12 primarily maintained in populations of African descent?

  • What selective pressures influenced CASP12 pseudogenization in most human populations?

  • How do CASP12 polymorphisms affect susceptibility to infection and inflammatory diseases?

• Regulatory mechanisms:

  • What factors control CASP12 expression in different tissues?

  • How is CASP12 activated in response to cellular stress?

  • What post-translational modifications regulate CASP12 function?

• Signaling pathway integration:

  • How does CASP12 balance its contradictory roles in inflammation?

  • What determines whether CASP12 promotes or inhibits NF-κB signaling?

  • How does CASP12 interact with other caspases in the inflammatory cascade?

• Therapeutic potential:

  • Can CASP12 be targeted to modulate inflammatory responses?

  • Would CASP12 inhibition be beneficial in treating inflammatory diseases or cancer?

  • How might CASP12-targeted therapies affect different populations based on genetic variations?

• Structural biology:

  • What is the three-dimensional structure of human CASP12?

  • How does CASP12 interact with the IKK complex at the molecular level?

  • What structural features explain CASP12's unique functions compared to other inflammatory caspases?

Addressing these questions will require interdisciplinary approaches combining molecular biology, genetics, structural biology, and clinical research.

How might CASP12 research translate to clinical applications?

CASP12 research shows potential for clinical translation in several areas:

• Biomarker development:

  • CASP12 expression patterns may serve as diagnostic or prognostic markers

  • Genetic testing for functional CASP12 variants could assess sepsis susceptibility

  • CASP12 activation status might indicate inflammatory disease activity

• Cancer therapeutics:

  • Research showing CASP12's role in NPC cell invasion suggests potential as a therapeutic target

  • CASP12 inhibitors like Z-ATAD-fmk could be developed as anti-metastatic agents

  • Combination therapies targeting CASP12 and downstream effectors might enhance efficacy

• Inflammatory disease treatment:

  • Modulating CASP12 activity could help regulate excessive inflammatory responses

  • Population-specific approaches might be necessary given genetic variation

  • Targeting CASP12-IKK interaction could provide novel anti-inflammatory strategies

• Sepsis management:

  • Functional CASP12 is linked to increased sepsis susceptibility

  • Early identification of at-risk patients could guide preventive measures

  • CASP12-targeted therapies might improve outcomes in specific patient populations

• Personalized medicine approaches:

  • Genetic screening for CASP12 variants could inform treatment decisions

  • Tailored therapeutic approaches based on CASP12 status might optimize outcomes

  • Integration with other genetic and biomarker data could enhance precision medicine